VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
STVNStevanato Group S.p.A.
$17.54$4.8B
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist

STVN logoStevanato Group S.p.A.(STVN)Earnings, Financials & Key Ratios

STVN•NYSE
31.1× P/E·Price updated Jun 19, 2026
SectorHealthcareIndustryMedical InstrumentsSub-IndustryDrug delivery and infusion consumables
AboutStevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for pharma and healthcare. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machines. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. operates as a subsidiary of Stevanato Holding S.R.L.Show more
  • Revenue$1.14B+3.2%
  • EBITDA$268M+10.9%
  • Net Income$134M+14.0%
  • EPS (Diluted)0.49+14.0%
  • Gross Margin28.99%+5.9%
  • EBITDA Margin23.54%+7.5%
  • Operating Margin16.07%+10.1%
  • Net Margin11.78%+10.5%
  • ROE9.29%

STVN Key Insights

Stevanato Group S.p.A. (STVN) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

  • ✓High quality earnings: Operating CF exceeds net income
  • ✓Strong 5Y sales CAGR of 11.5%
  • ✓Healthy 5Y average net margin of 13.3%

✗Weaknesses

  • ✗Trading more than 30% below 52-week high

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

Get notified when STVN posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

STVN Price & Volume

Stevanato Group S.p.A. (STVN) stock price & volume — 10-year historical chart

Loading chart...

STVN Growth Metrics

Stevanato Group S.p.A. (STVN) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years-
5 Years11.47%
3 Years5.02%
TTM6.7%

Profit CAGR

10 Years-
5 Years11.33%
3 Years-2.04%
TTM12.33%

EPS CAGR

10 Years-
5 Years11.84%
3 Years-2.58%
TTM9.54%

Return on Capital

10 Years13.7%
5 Years13.93%
3 Years11.34%
Last Year9.49%

STVN Recent Earnings

Stevanato Group S.p.A. (STVN) EPS & revenue vs analyst estimates — last 4 quarters

Full history →
●Beat EPS 6/12 qtrs (50%)●Beat Revenue 4/12 qtrs (33%)
Q2 2026Latest
May 7, 2026
Metric
Actual
Est
EPS
$0.13+8.3%
$0.12
Rev
$316M+1.8%
$310M
Q2 2026
Mar 4, 2026
Metric
Actual
Est
EPS
$0.21+5.0%
$0.20
Rev
$407M+4.0%
$391M
Q4 2025
Nov 6, 2025
Metric
Actual
Est
EPS
$0.16+14.3%
$0.14
Rev
$355M-7.9%
$385M
Q3 2025
Aug 5, 2025
Metric
Actual
Est
EPS
$0.12+9.1%
$0.11
Rev
$330M-3.9%
$343M
QuarterDateEPS (Act vs Est)Revenue (Act vs Est)
Q2 2026LatestMay 7, 2026
$0.13vs $0.12+8.3%
$316Mvs $310M+1.8%
Q2 2026Mar 4, 2026
$0.21vs $0.20+5.0%
$407Mvs $391M+4.0%
Q4 2025Nov 6, 2025
$0.16vs $0.14+14.3%
$355Mvs $385M-7.9%
Q3 2025Aug 5, 2025
$0.12vs $0.11+9.1%
$330Mvs $343M-3.9%
Based on last 12 quarters of dataView full earnings history →

STVN Peer Comparison

Stevanato Group S.p.A. (STVN) competitors in Drug delivery and infusion consumables — business model, growth, and fundamentals comparison

Select Columns
Stock Universe
Valuation
Growth
Profitability
Financial Health
Dividends & Buybacks
Price Performance
Technical
Fundamentals ($)
Sector-Specific
Institutional Holdings
CompanyMarket CapStock PriceP/E Ratio (TTM)Revenue Growth 1YNet MarginReturn on Equity (ROE)FCF YieldDebt / Equity
APOG logoAPOGApogee Enterprises, Inc.Direct Competitor887.72M41.2716.383.21%3.85%10.79%0.56
BCPC logoBCPCBalchem CorporationDirect Competitor5.31B165.9234.938.75%14.95%12.38%0.15
BDX logoBDXBecton, Dickinson and CompanyProduct Competitor52.16B143.9824.708.23%5.33%4.54%0.76
WST logoWSTWest Pharmaceutical Services, Inc.Product Competitor23.64B328.0348.246.26%16.85%17.87%0.13
GTLS logoGTLSChart Industries, Inc.Product Competitor9.96B207.99630.272.49%-0.63%-0.78%1.11
AVTR logoAVTRAvantor, Inc.Product Competitor6.54B9.58-12.28-3.41%-8.42%-9.59%0.71
AZTA logoAZTAAzenta, Inc.Product Competitor1.07B23.31-19.113.55%-29.86%-10.69%0.06
PFE logoPFEPfizer Inc.Supply Chain143.46B25.2218.54-1.65%11.83%8.34%0.78

Compare STVN vs Peers

Stevanato Group S.p.A. (STVN) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs APOG

Most directly comparable listed peer for STVN.

Scale Benchmark

vs LLY

Larger-name benchmark to compare STVN against a more recognizable public peer.

Peer Set

Compare Top 5

vs APOG, BCPC, BDX, WST

STVN Income Statement

Stevanato Group S.p.A. (STVN) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily
MetricDec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Sales/Revenue
536.54M662.04M843.92M983.68M1.09B1.1B1.14B1.2B
Revenue Growth %
-23.39%27.47%16.56%10.34%1.72%3.21%6.7%
Cost of Goods Sold
398.52M467.86M578.51M663.88M745.46M801.72M809.15M851.87M
COGS % of Revenue
74.28%70.67%68.55%67.49%68.68%72.62%71.01%-
Gross Profit
138.02M▲ 0%
194.18M▲ 40.7%
265.4M▲ 36.7%
319.8M▲ 20.5%
339.89M▲ 6.3%
302.32M▼ 11.1%
330.33M▲ 9.3%
348.16M▲ 0%
Gross Margin %
25.72%29.33%31.45%32.51%31.32%27.38%28.99%29.01%
Gross Profit Growth %
-40.69%36.68%20.5%6.28%-11.05%9.26%-
Operating Expenses
75.8M91.07M103.18M127.37M139.17M141.18M147.25M149.36M
OpEx % of Revenue
14.13%13.76%12.23%12.95%12.82%12.79%12.92%-
Selling, General & Admin
76.71M78.91M82.95M111.83M113.92M118.6M122.85M127.07M
SG&A % of Revenue
14.3%11.92%9.83%11.37%10.5%10.74%10.78%-
Research & Development
7.83M17.39M29.62M34.39M35.67M31.67M24.4M25.28M
R&D % of Revenue
1.46%2.63%3.51%3.5%3.29%2.87%2.14%-
Other Operating Expenses
-8.74M-5.23M-9.39M-18.85M-10.42M-9.09M0-1.27M
Operating Income
62.22M▲ 0%
103.11M▲ 65.7%
162.22M▲ 57.3%
192.43M▲ 18.6%
200.72M▲ 4.3%
161.14M▼ 19.7%
183.08M▲ 13.6%
198.8M▲ 0%
Operating Margin %
11.6%15.57%19.22%19.56%18.49%14.6%16.07%16.57%
Operating Income Growth %
-65.72%57.33%18.62%4.31%-19.72%13.61%-
EBITDA
108.44M157.21M218.61M257.25M279.2M241.79M268.18M291.17M
EBITDA Margin %
20.21%23.75%25.9%26.15%25.72%21.9%23.54%24.26%
EBITDA Growth %
-44.98%39.05%17.68%8.53%-13.4%10.91%-0.49%
D&A (Non-Cash Add-back)
46.22M54.1M56.38M64.82M78.48M80.65M85.1M92.37M
EBIT
60.32M102.27M170.54M191.58M193.87M167.15M183.08M198.09M
Net Interest Income
-5.1M-6.37M-4.32M-3.29M-3.52M-5.14M-9.32M-8.19M
Interest Income
195.87K424.07K548K648K792K1.72M12.49M1.01M
Interest Expense
5.3M6.79M4.87M3.94M4.32M6.86M21.8M9.2M
Other Income/Expense
-7.51M-6.83M3.45M-4.79M-11.17M-854K-1.44M-6.14M
Pretax Income
54.71M▲ 0%
96.28M▲ 76.0%
165.67M▲ 72.1%
187.64M▲ 13.3%
189.55M▲ 1.0%
160.29M▼ 15.4%
181.64M▲ 13.3%
192.66M▲ 0%
Pretax Margin %
10.2%14.54%19.63%19.08%17.46%14.52%15.94%16.05%
Income Tax
16.01M17.68M31.4M44.63M43.86M42.52M47.35M51.71M
Effective Tax Rate %
29.26%18.37%18.96%23.78%23.14%26.53%26.07%26.84%
Net Income
39.2M▲ 0%
78.51M▲ 100.3%
134.32M▲ 71.1%
142.85M▲ 6.3%
145.63M▲ 1.9%
117.78M▼ 19.1%
134.28M▲ 14.0%
140.95M▲ 0%
Net Margin %
7.31%11.86%15.92%14.52%13.42%10.67%11.78%11.75%
Net Income Growth %
-100.28%71.08%6.35%1.95%-19.13%14.01%12.33%
Net Income (Continuing)
38.71M78.6M134.27M143.02M145.69M117.77M134.28M140.94M
Discontinued Operations
00000000
Minority Interest
-50K-355K-415K-220K115K46K37.98K36K
EPS (Diluted)
0.15▲ 0%
0.28▲ 86.7%
0.53▲ 89.3%
0.53▲ 0.0%
0.55▲ 3.8%
0.43▼ 21.8%
0.49▲ 14.0%
0.52▲ 0%
EPS Growth %
-86.67%89.29%0%3.77%-21.82%13.95%9.54%
EPS (Basic)
0.150.280.530.530.550.430.49-
Diluted Shares Outstanding
264.7M264.7M264.7M264.7M264.98M272.88M273M273.02M
Basic Shares Outstanding
264.7M264.7M264.7M264.7M264.95M272.87M273M273M
Dividend Payout Ratio
15.74%11.34%8.34%9.45%9.82%12.27%10.54%-

STVN Balance Sheet

Stevanato Group S.p.A. (STVN) balance sheet — assets, liabilities & shareholders' equity

MetricDec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Total Current Assets
449.58M492.77M865.97M845.77M861.89M880.12M934.4M914.36M
Cash & Short-Term Investments
126.27M157.12M438.21M256.65M70.35M98.27M132.74M112.73M
Cash Only
85.39M115.6M411.04M228.74M69.6M98.27M130.54M111.67M
Short-Term Investments
40.88M41.52M27.17M27.91M749K02.2M1.06M
Accounts Receivable
160.58M167.25M278.42M369.48M522.48M529.87M542.17M506.66M
Days Sales Outstanding
109.2492.21120.42137.1175.71175.18173.67153.56
Inventory
131.88M139.37M148.92M213.25M255.32M245.22M268.09M294.36M
Days Inventory Outstanding
120.79108.7393.96117.25125.01111.64120.93119.03
Other Current Assets
30.55M28.62M49K5.69M3.63M933K-8.6M606K
Total Non-Current Assets
432.6M475.2M552.87M813.92M1.21B1.45B1.61B1.67B
Property, Plant & Equipment
306.93M339.04M415.41M660.69M1.05B1.26B1.4B1.47B
Fixed Asset Turnover
1.75x1.95x2.03x1.49x1.04x0.87x0.81x0.87x
Goodwill
47.24M47.24M47.24M47.24M49.98M49.98M49.96M49.98M
Intangible Assets
34.82M33.9M31.93M32.16M30.98M33.59M36.85M36.56M
Long-Term Investments
4.61M3.51M1.97M1.83M5.15M5.64M6M22.6M
Other Non-Current Assets
5.9M5.96M447K2.79M577K08.6M893K
Total Assets
882.18M▲ 0%
967.98M▲ 9.7%
1.42B▲ 46.6%
1.66B▲ 17.0%
2.07B▲ 24.8%
2.33B▲ 12.4%
2.54B▲ 9.2%
2.58B▲ 0%
Asset Turnover
0.61x0.68x0.59x0.59x0.52x0.47x0.45x0.49x
Asset Growth %
-9.73%46.58%16.98%24.82%12.42%9.19%36.43%
Total Current Liabilities
262.94M316.18M338.62M462.5M574.39M477.47M535.57M560.27M
Accounts Payable
95.05M118.74M164.79M239.18M277.81M231.02M263.19M254.36M
Days Payables Outstanding
87.0692.63103.97131.5136.03105.18118.72101.96
Short-Term Debt
65.35M63.45M37.17M64.63M135.6M106.84M121.69M119.32M
Deferred Revenue (Current)
50.43M56.9M50.61M53.89M58.8M44.67M43.78M179.21M
Other Current Liabilities
10.83M17.49M5.33M-3.73M11.15M15.45M106.91M91.92M
Current Ratio
1.71x1.56x2.56x1.83x1.50x1.84x1.74x1.63x
Quick Ratio
1.21x1.12x2.12x1.37x1.06x1.33x1.24x1.11x
Cash Conversion Cycle
142.97108.31110.41122.84164.69181.64175.88170.63
Total Non-Current Liabilities
353.8M341.66M238.56M201.29M364.54M446.96M521.38M492.73M
Long-Term Debt
290.88M273.94M183.99M133.75M242.05M305.23M337.64M312.57M
Capital Lease Obligations
21.26M20.19M17.57M14.66M13.1M11.81M9.37M39.94M
Deferred Tax Liabilities
011.62M19.11M20.95M9.62M12.56M13.29M54.1M
Other Non-Current Liabilities
41.66M35.92M17.89M31.93M60.35M73.32M62.07M11.34M
Total Liabilities
616.74M657.84M577.18M663.79M938.93M924.43M1.06B1.05B
Total Debt
375.67M363.01M244.29M218.37M396.59M428.97M470.7M448.52M
Net Debt
290.28M247.41M-166.75M-10.37M326.99M330.7M340.16M336.85M
Debt / Equity
1.42x1.17x0.29x0.22x0.35x0.31x0.32x0.29x
Debt / EBITDA
3.46x2.31x1.12x0.85x1.42x1.77x1.76x1.54x
Net Debt / EBITDA
2.68x1.57x-0.76x-0.04x1.17x1.37x1.27x1.16x
Interest Coverage
11.38x15.06x35.01x48.67x44.93x24.35x8.40x21.53x
Total Equity
265.44M▲ 0%
310.14M▲ 16.8%
841.66M▲ 171.4%
995.91M▲ 18.3%
1.13B▲ 13.7%
1.4B▲ 24.0%
1.49B▲ 5.8%
1.53B▲ 0%
Equity Growth %
-16.84%171.38%18.33%13.73%23.99%5.8%28.19%
Book Value per Share
1.001.173.183.764.275.155.445.61
Total Shareholders' Equity
265.49M310.5M842.07M996.13M1.13B1.4B1.49B1.53B
Common Stock
20M20M21.7M21.7M21.7M22.23M22.22M22.23M
Retained Earnings
000623.35M757.86M863.44M876.41M1.02B
Treasury Stock
000-27.74M-27.23M-27.15M-27.07M-27.08M
Accumulated OCI
206.29M211.98M686.05M-10.49M-9.11M-13.75M54.95M-43.54M
Minority Interest
-50K-355K-415K-220K115K46K37.98K36K

STVN Cash Flow Statement

Stevanato Group S.p.A. (STVN) cash flow — operating, investing & free cash flow history

MetricDec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Cash from Operations
42.57M155.66M133.34M103.31M105.21M155.78M274.79M260.08M
Operating CF Margin %
7.93%23.51%15.8%10.5%9.69%14.11%24.12%-
Operating CF Growth %
-265.63%-14.34%-22.52%1.84%48.06%76.4%131%
Net Income
54.71M96.28M165.67M187.64M189.55M160.29M134.32M140.95M
Depreciation & Amortization
46.22M54.1M56.38M64.82M78.48M80.65M83.9M91.15M
Stock-Based Compensation
00000000
Deferred Taxes
00000000
Other Non-Cash Items
-33.39M-27.9M-47.09M-31.41M-60.34M-67.76M7.94M-18.81M
Working Capital Changes
-24.97M33.18M-41.63M-117.74M-102.48M-17.41M48.63M13.11M
Change in Receivables
5.87M-3.63M-54.77M-46.42M-93.86M-3.83M855.83K-28.64M
Change in Inventory
-42.67M-15.6M-31.2M-107.37M-113.59M12.31M-39.82M-28M
Change in Payables
11.84M52.41M44.34M36.05M104.97M-25.89M87.59M69.75M
Cash from Investing
-74.34M-96.09M-96.43M-242.95M-421.22M-310.21M-262.15M-271.01M
Capital Expenditures
-68.09M-89.56M-107.69M-235.03M-433.23M-302.6M-264.18M-263.26M
CapEx % of Revenue
12.69%13.53%12.76%23.89%39.92%27.41%23.18%21.94%
Acquisitions
0014.81M0-3.59M-175K1.79M224.31K
Investments
--------
Other Investing
-5.62M-6.42M-4.32M-7.95M15.6M-7.44M0-8.14M
Cash from Financing
42.17M-26.52M254.85M-44.54M158.03M183.22M21.19M32.7M
Debt Issued (Net)
48.34M-17.08M-120.18M-31.04M172.57M27.91M41.38M47.62M
Equity Issued (Net)
00380.09M00169.77M00
Dividends Paid
-6.17M-8.9M-11.2M-13.5M-14.29M-14.46M-14.16M58.88K
Share Repurchases
00000000
Other Financing
0-539K6.13M0-250K0-6.03M-14.98M
Net Change in Cash
10.87M▲ 0%
30.21M▲ 178.0%
295.44M▲ 877.9%
-182.3M▼ 161.7%
-159.14M▲ 12.7%
28.67M▲ 118.0%
43.94M▲ 53.3%
21.32M▲ 0%
Free Cash Flow
-31.33M▲ 0%
59.65M▲ 290.4%
20.16M▼ 66.2%
-139.81M▼ 793.7%
-336.72M▼ 140.8%
-157.79M▲ 53.1%
21.44M▲ 113.6%
-7.11M▲ 0%
FCF Margin %
-5.84%9.01%2.39%-14.21%-31.02%-14.29%1.88%-0.59%
FCF Growth %
-290.37%-66.21%-793.66%-140.83%53.14%113.59%95.91%
FCF per Share
-0.120.230.08-0.53-1.27-0.580.08-0.03
FCF Conversion (FCF/Net Income)
1.09x1.98x0.99x0.72x0.72x1.32x2.05x-0.05x
Interest Paid
00000000
Taxes Paid
00000000

STVN Key Ratios

Stevanato Group S.p.A. (STVN) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric202020212022202320242025TTM
Return on Equity (ROE)
27.28%23.32%15.55%13.68%9.28%9.29%9.63%
Return on Invested Capital (ROIC)
13.89%19.74%17.38%12.31%7.57%7.71%8.3%
Gross Margin
29.33%31.45%32.51%31.32%27.38%28.99%29.01%
Net Margin
11.86%15.92%14.52%13.42%10.67%11.78%11.75%
Debt / Equity
1.17x0.29x0.22x0.35x0.31x0.32x0.29x
Interest Coverage
15.06x35.01x48.67x44.93x24.35x8.40x21.53x
FCF Conversion
1.98x0.99x0.72x0.72x1.32x2.05x-0.05x
Revenue Growth
23.39%27.47%16.56%10.34%1.72%3.21%6.7%
Related:STVN Dividend History·STVN Revenue History·STVN Price History·STVN P/E History·STVN Financial Ratios·STVN Institutional Holders

STVN Frequently Asked Questions

Stevanato Group S.p.A. (STVN) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

Stevanato Group S.p.A. (STVN) reported $1.20B in revenue for fiscal year 2025. This represents a 124% increase from $536.5M in 2019.

Stevanato Group S.p.A. (STVN) grew revenue by 3.2% over the past year. Growth has been modest.

Yes, Stevanato Group S.p.A. (STVN) is profitable, generating $140.9M in net income for fiscal year 2025 (11.8% net margin).

Dividend & Returns

Yes, Stevanato Group S.p.A. (STVN) pays a dividend with a yield of 0.34%. This makes it attractive for income-focused investors.

Stevanato Group S.p.A. (STVN) has a return on equity (ROE) of 9.3%. This is below average, suggesting room for improvement.

Stevanato Group S.p.A. (STVN) had negative free cash flow of $7.1M in fiscal year 2025, likely due to heavy capital investments.

What if you invested $1,000 in STVN back in 2019?

Total return calculator · dividends reinvested · 7+ years of data

See returns →

How much would $100/month in STVN be worth today?

Dollar cost averaging calculator · DCA vs lump sum

Calculate →